YWHAB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.630600E-01
Normal-vs-Stage2
5.596800E-01
Normal-vs-Stage3
1.801760E-01
Normal-vs-Stage4
7.470600E-01
Stage1-vs-Stage2
4.561800E-01
Stage1-vs-Stage3
5.922600E-01
Stage1-vs-Stage4
1.712830E-01
Stage2-vs-Stage3
2.059600E-01
Stage2-vs-Stage4
3.083000E-01
Stage3-vs-Stage4
1.295980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.838800E-01
Normal-vs-AfricanAmerican
9.693000E-01
Normal-vs-Asian
3.502400E-01
Caucasian-vs-AfricanAmerican
3.601200E-01
Caucasian-vs-Asian
6.617800E-01
AfricanAmerican-vs-Asian
3.024600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.978800E-01
Normal-vs-Female
4.197400E-01
Male-vs-Female
5.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.161000E-01
Normal-vs-Age(41-60Yrs)
8.962000E-01
Normal-vs-Age(61-80Yrs)
3.668400E-01
Normal-vs-Age(81-100Yrs)
6.061400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.023600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.508400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.210400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.639900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.273600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.486000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.941600E-01
Normal-vs-Daily Drinker
4.731000E-01
Normal-vs-Weekly Drinker
2.967800E-01
Normal-vs-Occasional Drinker
9.023400E-01
Normal-vs-Social Drinker
2.608200E-01
Non Drinker-vs-Daily Drinker
7.041400E-01
Non Drinker-vs-Weekly Drinker
8.781000E-01
Non Drinker-vs-Occasional Drinker
2.115600E-02
Non Drinker-vs-Social Drinker
7.792400E-01
Daily Drinker-vs-Weekly Drinker
8.546800E-01
Daily Drinker-vs-Occasional Drinker
9.864300E-02
Daily Drinker-vs-Social Drinker
9.243000E-01
Weekly Drinker-vs-Occasional Drinker
5.512200E-02
Weekly Drinker-vs-Social Drinker
9.112200E-01
Occasional Drinker-vs-Social Drinker
5.034200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.464800E-01
Normal-vs-Grade 2
7.281600E-01
Normal-vs-Grade 3
6.900000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.924200E-02
Grade 1-vs-Grade 3
1.970190E-02
Grade 1-vs-Grade 4
8.464800E-01
Grade 2-vs-Grade 3
3.596000E-01
Grade 2-vs-Grade 4
7.281600E-01
Grade 3-vs-Grade 4
6.900000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.694000E-01
Normal-vs-NonDiabetic
5.072400E-01
Diabetic-vs-NonDiabetic
1.986190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.928800E-01
Normal-vs-NoPancreatitis
4.792400E-01
Pancreatitis-vs-NoPancreatitis
8.372400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.585000E-01
Normal-vs-N1
5.670800E-01
N0-vs-N1
8.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.296000E-01
Normal-vs-TP53-NonMutant
3.233400E-01
TP53-Mutant-vs-TP53-NonMutant
7.95340000000477E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
